Larimar Therapeutics Cash Flow Statement (2013-2025) | LRMR

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Operating Activities
Net Income (Quarter)	-21.80M	-21.94M	-19.69M	-133.10M	-17.39M	-11.18M	-10.86M	-141.27M	-9.70M	-16.62M	-17.60M	-155.93M	-27.73M	-34.40M	-25.66M	-204.32M	-37.23M	-28.98M	-50.69M	-65.52M
Depreciation and Depletion (Quarter)	0.10M	0.05M	0.10M	0.09M	0.08M	0.08M	0.08M	0.08M	0.08M	0.08M	0.08M	0.08M	0.08M	0.09M	0.07M	0.08M	0.09M	0.09M	0.09M	0.09M
Share-based Compensation (Quarter)	1.18M	1.35M	1.46M	1.48M	1.64M	1.68M	1.67M	1.64M	1.83M	2.04M	1.82M	1.92M	2.13M	2.30M	1.96M	8.33M	3.20M	1.83M	2.50M	1.56M
Cash from Restructuring (Quarter)
Cash from Operations (Quarter)	-11.21M	-10.78M	-12.20M	-7.92M	-7.53M	-7.49M	-5.88M	-6.67M	-7.55M	-7.37M	-9.20M	-9.38M	-10.41M	-13.99M	-24.55M	-21.82M	-26.54M	-19.38M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	-0.01M	-0.01M	-0.00M	-0.00M			-0.06M	-0.71M	-0.62M	-0.03M	-0.56M	3.05M	-0.58M	-1.78M	-1.71M	-1.18M	-0.76M	-0.46M	-0.33M	-0.16M
Amortization of Deferred Charges (Quarter)
Depreciation & Amortization (CF) (Quarter)	0.10M	0.05M	0.10M	0.09M	0.08M	0.08M	0.08M	0.08M	0.08M	0.08M	0.08M	0.08M	0.08M	0.09M	0.07M	0.08M	0.09M	0.09M	0.09M	0.09M
Change in Working Capital
Change in Account Payables (Quarter)	0.56M	-2.03M	0.59M	-0.10M	0.66M	-1.89M	0.34M	0.92M	-0.99M	1.65M	-1.59M	0.53M	0.29M	1.34M	-1.22M	0.74M	-0.15M	1.87M	6.90M	-5.83M
Change in Accured Expenses (Quarter)	-1.23M	1.06M	2.29M	-1.37M	-0.75M	0.82M	1.03M	0.72M	-1.68M	-2.36M	0.73M	2.29M	2.66M	7.10M	-3.63M	7.30M	-2.12M	2.60M	11.31M	25.76M
Other Working Capital Changes (Quarter)	-0.62M	-1.28M	-0.18M	-1.12M	0.21M	-0.49M	0.61M	-0.12M	-0.37M	0.34M	0.61M	0.49M	0.27M	1.41M	4.48M	2.30M	-3.89M	-0.93M	0.76M	-2.62M
Investing Activities
Capital Expenditures (Quarter)	0.33M	-0.08M	-0.24M	0.32M	-0.00M	0.10M	-0.13M	-0.01M	-0.01M	0.01M	-0.01M	0.17M	0.02M	-0.04M	0.36M	0.18M	-0.01M	0.08M	-0.12M	-0.02M
Change in Acquisitions & Divestments (Quarter)	7.00M	19.25M		6.50M				19.75M	92.25M	0.01M	9.99M	32.50M	16.50M	18.50M	50.00M	58.00M	67.00M	46.50M	36.50M	34.00M
Cash from Investing Activities (Quarter)	5.25M	19.22M	-6.79M	6.49M			-3.38M	-52.23M	92.25M	-9.84M	-46.43M	-2.63M	-68.36M	-63.49M	27.27M	19.20M	14.45M	18.84M
Financing Activities
Other financing activities (Quarter)
Cash from Financing Activities (Quarter)								-0.32M					162.15M	-0.33M	0.03M	0.04M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)			19.68M					-0.32M					162.15M	-0.34M						-0.20M
Additional items
Change in Cash (Quarter)	-5.96M	8.44M	0.90M	-1.43M	-7.53M	-42.83M	66.31M	-59.22M	84.70M	-17.20M	-55.60M	-11.97M	83.38M	-77.81M	2.76M	-2.58M	-12.09M	-0.54M	69.55M	-4.73M
Free Cash Flow (Quarter)	-11.54M	-10.70M	-11.96M	-8.24M	-7.53M	-7.59M	-5.75M	-6.67M	-7.54M	-7.38M	-9.19M	-9.55M	-10.43M	-13.95M	-24.91M	-21.99M	-26.53M	-19.46M	0.12M	0.02M
Net Cash Flow (Quarter)	-5.96M	8.44M	-18.99M	-1.43M	-7.53M	-7.49M	-9.26M	-59.22M	84.70M	-17.20M	-55.63M	-12.01M	83.38M	-77.81M	2.76M	-2.58M	-12.09M	-0.54M

Research Tools

Developers

Larimar Therapeutics Cash Flow Statement (2013-2025) | LRMR

Research Tools

Developers

Larimar Therapeutics Cash Flow Statement (2013-2025) | LRMR

Create an account

Sign In

Reset Password